Mathieu Roumiguie

21PUBLICATIONS
113CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Groundwater quality processes and contaminated land assessmentHaematological tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 31, 2026
A High Density of Impaired Tertiary Lymphoid Structures Is Associated with Higher Tumor Stage and Recurrence in Non-Muscle-Invasive Bladder Cancer.

|Oct 06, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

Francesco Pellegrino, Mario de Angelis, Pietro Scilipoti

|Apr 21, 2025
External validation of current quality care metrics after radical nephroureterectomy.

Igor Duquesne, Pierre-Etienne Gabriel, Mohamad Abou Chakra

|Feb 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Nadine Houédé, Thierry Chevallier, François Audenet

|Aug 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.

Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell

|Jul 04, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding.

Luca Antonelli, Pedro David Wendel-Garcia, Manja Deforth

Pageof 4

Frequent Collaborators

6 joint publications

Guillaume Ploussard

4 joint publications

Jeremy Yuen-Chun Teoh

3 joint publications

Francesco Soria

3 joint publications

Simone Albisinni